Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD).

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01569373

Enrollment

Registered

2012-04-03

Start date

2012-03-31

Completion date

2017-10-31

Last updated

2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Stem Cell Transplant Failure

Keywords

Allogeneic stem cell transplant, Graft versus Host Disease, GVHD

Brief summary

Samples of blood and urine will be analyzed for biomarkers to check their predictivity of Graft-versus-Host Disease (GVHD) outcomes.

Detailed description

To determine if serum biomarkers of inflammation correlate with onset and severity of acute GVHD, particularly GVHD of the gut.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years old or older patients * Undergoing allogeneic stem cell transplant

Exclusion criteria

None

Design outcomes

Primary

Measure	Time frame
Diagnosis of severe acute GVHD	2 months

Countries

United States

Outcome results